REQUEST A DEMO
Total
USD $0.00
Search more companies

Indar PrAT Po Vyrobnytstvu Insuliniv (Ukraine)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Indar PrAT Po Vyrobnytstvu Insuliniv Profile Updated: September 18, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Russian Download a sample report

Indar PrAT Po Vyrobnytstvu Insuliniv is a company based in Ukraine, with its head office in Kyiv. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on October 31, 1997. There are currently 336 (2018) people employed by Indar PrAT Po Vyrobnytstvu Insuliniv. In 2018, the company reported a net sales revenue increase of 113.5%. Its’ total assets recorded a growth of 32.7%. The net profit margin of Indar PrAT Po Vyrobnytstvu Insuliniv increased by 0.65% in 2018.

Headquarters
vul. Zroshuvalna, bud. 5
Kyiv; Kiev;

Contact Details: Purchase the Indar PrAT Po Vyrobnytstvu Insuliniv report to view the information.

Website: http://www.indar.com.ua

Basic Information
Total Employees:
Purchase the Indar PrAT Po Vyrobnytstvu Insuliniv report to view the information.
Registered Capital:
Purchase the Indar PrAT Po Vyrobnytstvu Insuliniv report to view the information.
Incorporation Date:
October 31, 1997
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Chief Accountant
Ownership Details
Purchase this report to view the information.
70.7%
Company Performance
Financial values in the chart are available after Indar PrAT Po Vyrobnytstvu Insuliniv report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
113.5%
Total operating revenue
104.42%
Operating profit (EBIT)
173.99%
EBITDA
36.79%
Net Profit (Loss) for the Period
340.3%
Total assets
32.7%
Total equity
-6.09%
Operating Profit Margin (ROS)
0.47%
Net Profit Margin
0.65%
Return on Equity (ROE)
2.51%
Quick Ratio
-0.07%
Cash Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?